To determine the effects of KIRA8 on human myeloma cells, we used IM-9 cells, which exhibit splicing of XBP1 mRNA even at the baseline (21.8% of spliced to total XBP1 mRNA ratio) (Figure 2B). This evidence concerns the gene XBP1 and plasma cell myeloma.